Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Late urinary function after prostate brachytherapy.

Daniel Landis1, Kent Wallner, Jacob Locke

  • 1Department of Radiation Oncology, University of Washington, Seattle, WA, USA.

Brachytherapy
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial.

JMIR research protocols·2026
Same author

Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103.

Brachytherapy·2026
Same author

Long-term prostate cancer survival outcomes including patterns of death in men >=75 years of age treated with low dose rate brachytherapy.

BMC geriatrics·2025
Same author

Comparison of integrated biological effectiveness of eye plaques with <sup>125</sup>I and <sup>103</sup>Pd photon sources using equivalent uniform RBE-weighted dose.

Medical physics·2025
Same author

Brachytherapy monotherapy for favorable and select unfavorable intermediate risk prostate cancer.

Prostate cancer and prostatic diseases·2025
Same author

Simultaneous conjunctival melanomas in one eye treated with both adjuvant brachytherapy and proton beam radiotherapy.

American journal of ophthalmology case reports·2025
Same journal

Addressing barriers to care: A proposed model to predict prolonged treatment time among patients with locally advanced cervical cancer.

Brachytherapy·2026
Same journal

EM-tracked MR-US live fusion and needle location in gynecologic brachytherapy.

Brachytherapy·2026
Same journal

Contour and dosimetric evaluation of an in-room mobile CBCT scanner for cylinder based brachytherapy.

Brachytherapy·2026
Same journal

Brachytherapy for rectal cancer: An overview of clinical competency development in contemporary practice.

Brachytherapy·2026
Same journal

Deep learning-based automatic segmentation of rectal tumors in endoscopic images.

Brachytherapy·2026
Same journal

Online educational program for CT-based image-guided adaptive brachytherapy in cervical cancer: The BrachyAcademy experience.

Brachytherapy·2026
See all related articles

Short-term urinary retention after prostate brachytherapy is common but typically resolves spontaneously within two years. Long-term urinary dysfunction is not clearly linked to pre-treatment clinical factors.

Area of Science:

  • Urology
  • Oncology
  • Radiation Therapy

Background:

  • Prostate brachytherapy is a common treatment for prostate cancer.
  • Understanding post-treatment morbidity is crucial for patient management.

Purpose of the Study:

  • To investigate the relationship between short-term and long-term morbidity after prostate brachytherapy.

Main Methods:

  • Patients completed the American Urological Association (AUA) questionnaire.
  • Pre-implant uroflowmetry and postvoid residual (PVR) were assessed.
  • Patients received either palladium-103 or iodine-125 brachytherapy.

Main Results:

  • 43% of patients experienced post-implant urinary retention, usually resolving within 24 hours.

Related Experiment Videos

  • All retention cases resolved spontaneously by two years without surgical intervention.
  • No clear correlation was found between long-term AUA score changes and pre-implant clinical variables.

    • Conclusions:

    • Post-implant urinary retention is a frequent but generally transient complication.
    • Long-term urinary dysfunction following prostate brachytherapy appears multifactorial and is not well-defined by current clinical predictors.